Skip to content

Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD)

Pathogenesis and Outcomes of Sleep Disordered Breathing in COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01764165
Enrollment
52
Registered
2013-01-09
Start date
2012-08-31
Completion date
2016-10-31
Last updated
2016-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, Sleep, Supplemental oxygen, Breathing mechanics, nasal insufflation

Brief summary

This research is being conducted to examine the effects of nasal insufflation of warm and humidified air through a small nasal cannula on sleep, breathing pulmonary function, and daytime exercise capability.

Detailed description

Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity including substantial daytime fatigue exertional intolerance and ventilatory impairment, which hits a nadir in the morning. Nocturnal disturbances in sleep and breathing are common in COPD, although the impact of these disturbances on COPD morbidity remains largely unknown. The hypothesis is that COPD induces specific sleep and breathing disturbances that remain a substantial source of morbidity in this disorder. Current therapy for treating nocturnal disturbances in sleep and breathing in COPD including nocturnal oxygen has failed to improve morning fatigue and pulmonary function. This study promises to significantly alter our approach to the diagnosis and management of sleep disordered breathing in COPD.

Interventions

OTHEROxygen

oxygen at a rate of 2 L/min will be delivered through a small nasal cannula throughout sleep.

OTHERHigh flow of room air

Warm and humidified air at rates of 20 L/min will be delivered through a small nasal cannula throughout sleep

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Consenting adults over the age of 21 * BMI \< 40 kg/m2

Exclusion criteria

* Diagnosed with sleep apnea (apnea and hypopneas of \>10 events/hr). * A sleep efficiency of \<30%, or a prior diagnosis of disorders that impair sleep architecture. * Unstable cardiovascular disease (decompensated heart failure, myocardial infarction within the past 3 months, revascularization procedure within the past 3 months, unstable arrhythmias, uncontrolled hypertension (BP \> 190/110)). * Severe renal insufficiency requiring dialysis. * Liver cirrhosis. * A recent acute illness in a 6 weeks period prior to the sleep studies. * We will exclude subjects with severe daytime hypoxemia (Oxyhemoglobin saturation (SaO2) \<80% or partial pressure of oxygen (PaO2) \<55 mmHg at rest). * Chronic use of sedatives or respiratory depressants that would affect sleep quality (e.g., benzodiazepines or other hypnotics or narcotics). * Pregnancy. * Tracheostomy or other significant oropharyngeal or nasopharyngeal surgery, in the last 6 months. * Narcolepsy and other neurological disorders such as Parkinson's Disease. * Severe hepatic insufficiency. * Bleeding disorders or Coumadin use. * Allergy to lidocaine or benzocaine. * Language/dementia/psychiatric issues - the participant must be able to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
The evening to morning differences in expiratory airflow obstruction (FEV1/FVC)4 yearsLung function declines over the course of the night. We hypothesize that delivering warm and humidified air at a rate of 20 L/min over the entire night improves morning FEV1 compared to oxygen.

Secondary

MeasureTime frameDescription
The percent rate of inspiratory flow limitation.4 YearsPatients with COPD often exhibit inspiratory air flow limitation during sleep. We hypothesize that delivering warm and humidified air at a rate of 20 L/min reduces the degree of inspiratory air flow limitation compared to oxygen.
Effect of High flow nasal insufflation of air on exercise capacity (6 minute walk test).One YearPatients with COPD have impaired exercise tolerance in the morning. We hypothesize that delivering warm and humidified air at a rate of 20 L/min over the entire night extends morning 6 minute walk length.

Other

MeasureTime frameDescription
Sleep efficiency4 yearsWe hypothesize that delivering warm and humidified air at a rate of 20 L/min over the entire night improves sleep efficiency compared to oxygen treatment.
Episodes of dynamic hyperinflation4 yearsThe combination of in- and expiratory flow limitation can lead to dynamic hyperinflation during sleep. We hypothesize that compared to oxygen, high flow nasal insufflation of warm and humidified air at a rate of 20 L/min will reduce the number of breaths associated with dynamic hyperinflation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026